Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne’s syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues

Meenakshi Dabholkar, Keith Thornton, Justine Vionnet, Jing Yu, Eddie Reed

Biochemical Pharmacology · 2000 · 38 citations · 37 references

Concepts

References

37